Canadian Biotech Company Pursuing Psychedelics with Unique Compound

Research from BetterLife Pharma indicates promising potential from an LSD derivative molecule known as TD-0148A, whose medical impact is not marred by the psychoactive effects of the well-known psychedelic drug.

Category Popular Press
Published in Investing News Network
?>